These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 21954124

  • 1. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
    Budde MD, Gold E, Jordan EK, Smith-Brown M, Frank JA.
    NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
    [Abstract] [Full Text] [Related]

  • 2. Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T.
    Song HT, Jordan EK, Lewis BK, Gold E, Liu W, Frank JA.
    NMR Biomed; 2011 Apr; 24(3):325-34. PubMed ID: 20949637
    [Abstract] [Full Text] [Related]

  • 3. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
    Song HT, Jordan EK, Lewis BK, Liu W, Ganjei J, Klaunberg B, Despres D, Palmieri D, Frank JA.
    J Transl Med; 2009 Oct 20; 7():88. PubMed ID: 19840404
    [Abstract] [Full Text] [Related]

  • 4. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J, Kim E, Euceda LR, Meyer DE, Langseth K, Bathen TF, Moestue SA, Huuse EM.
    J Magn Reson Imaging; 2018 Jun 20; 47(6):1589-1600. PubMed ID: 29205621
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A, Hou LC, Hsu AR, Cai W, Greve JM, Chen X, Tse V.
    Neurol Res; 2008 Nov 20; 30(9):952-9. PubMed ID: 18662497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.
    Zhou H, Chen M, Zhao D.
    PLoS One; 2013 Nov 20; 8(4):e62238. PubMed ID: 23638013
    [Abstract] [Full Text] [Related]

  • 12. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
    Monsky WL, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D, Jain RK.
    Clin Cancer Res; 2002 Apr 20; 8(4):1008-13. PubMed ID: 11948107
    [Abstract] [Full Text] [Related]

  • 13. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
    Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M.
    Neoplasia; 2001 Apr 20; 3(2):143-53. PubMed ID: 11420750
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.
    Kim E, Lee E, Plummer C, Gil S, Popel AS, Pathak AP.
    Angiogenesis; 2015 Apr 20; 18(2):125-36. PubMed ID: 25408417
    [Abstract] [Full Text] [Related]

  • 16. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
    Cyran CC, Sennino B, Fu Y, Rogut V, Shames DM, Chaopathomkul B, Wendland MF, McDonald DM, Brasch RC, Raatschen HJ.
    Eur J Radiol; 2012 May 20; 81(5):891-6. PubMed ID: 21889860
    [Abstract] [Full Text] [Related]

  • 17. In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.
    Pathak AP, McNutt S, Shah T, Wildes F, Raman V, Bhujwalla ZM.
    PLoS One; 2013 May 20; 8(5):e63146. PubMed ID: 23650550
    [Abstract] [Full Text] [Related]

  • 18. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM.
    Magn Reson Imaging; 2007 Apr 20; 25(3):319-27. PubMed ID: 17371720
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.